CLINICO-MOLECULAR INFORMATICS

Serial Number 85583393
602

Registration Progress

Application Filed
Mar 29, 2012
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

CLINICO-MOLECULAR INFORMATICS

Basic Information

Serial Number
85583393
Filing Date
March 29, 2012
Abandonment Date
December 1, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jan 8, 2016
Classes
035 042 044

Rights Holder

MOLECULAR HEALTH GMBH

16
Address
BELFORTSTRASSE 2
HEIDELBERG 69115
DE

Ownership History

Molecular Health AG

Original Applicant
99
4010 Basel CH

MOLECULAR HEALTH GMBH

New Owner Before Publication #1
16
HEIDELBERG DE

Legal Representation

Attorney
Andrew Baum

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Jan 8, 2016 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jan 8, 2016 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Oct 19, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
May 28, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 28, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 28, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 5, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 5, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 28, 2015 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 28, 2014 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Oct 28, 2014 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Oct 28, 2014 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Oct 2, 2014 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Aug 20, 2014 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 1, 2014 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 1, 2014 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 1, 2014 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 20, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 20, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2014 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 2, 2013 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Oct 2, 2013 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Oct 2, 2013 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Sep 19, 2013 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Mar 15, 2013 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 15, 2013 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Mar 15, 2013 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 7, 2013 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 7, 2013 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 7, 2013 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 7, 2013 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 31, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 31, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2013 ALIE A ASSIGNED TO LIE Loading...
Jan 22, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 22, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 23, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 23, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 23, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 10, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 2, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of "CLINICO" in the mark is CLINICAL.

Classification

International Classes
035 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INFORMATICS"